Epstein Secrets

Board of Directors of CV Therapeutics, and Merck and Company. Robert Dow, BSc MBChB FRCP (Edln) Dr. Dow's current position is as Vice President of Strategic Product Development for PPD, a global Contract Research Organization. Previously, Dr. Dow served as Chief Medical Officer and Senior Vice President of medical affairs

- Perkin Elmer, President of Life Sciences & Technology ■ Dan Junius - lmmunogen, CEO • Al Sommers - JHU, Former Dean, School of Public Health • Chris Jones - J Walter Thompson, former CEO • Bill Halter - Lt. Governor, Arkansas DACART CAPITAL LLC EFTA_R1_01138849 EFTA02295575 DA CART CAPITAL L LC San Francisco, Califo

Board of Directors of CV Therapeutics, and Merck and Company. Robert Dow, BSc MBChB FRCP (Edin) Dr. Dow's current position is as Vice President of Strategic Product Development for PPD, a global Contract Research Organization. Previously, Dr. Dow served as Chief Medical Officer and Senior Vice President of medical affairs

- Perkin Elmer, President of Life Sciences & Technology • Dan Junius - Immunogen, CEO • Al Sommers - JHU, Former Dean, School of Public Health • Chris Jones - J Walter Thompson, former CEO 111 • Bill Halter - Lt. Governor, Arkansas DAC .ART C:APITAL EFTA00506154 DACART CAPITAL LLC San Francisco, California: Where Biot

Board of Directors of CV Therapeutics, and Merck and Company. Robert Dow, BSc MBChB FRCP (Edin) Dr. Dow's current position is as Vice President of Strategic Product Development for PPD, a global Contract Research Organization. Previously, Dr. Dow served as Chief Medical Officer and Senior Vice President of medical affairs

Partner • Kevin Hrusovsky - Caliper Life Sciences, CEO • Dan Junius - lmmunogen, CEO • Al Sommers - JHU, Former Dean, School of Public Health • Chris Jones - J Walter Thompson, former CEO Bi l l • Halter - Li. Governor, Arkansas DAC:ART CAPITAL LL, I I /1 EFTA00506201 DACART CAPITAL LLC A Distinguished Building